ALBIREO PHARMA, INC.·4

Jan 23, 7:28 PM ET

Horn Patrick Taylor 4

4 · ALBIREO PHARMA, INC. · Filed Jan 23, 2020

Insider Transaction Report

Form 4
Period: 2020-01-21
Horn Patrick Taylor
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-01-22$24.29/sh443$10,7604,557 total
  • Award

    Stock Option (right to buy)

    2020-01-21+31,50031,500 total
    Exercise: $24.67Exp: 2030-01-20Common Stock (31,500 underlying)
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 807 shares of common stock and 3,750 restricted stock units.
  • [F3]This option vests as to 25% of the shares on January 21, 2021, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2021 and ending on January 21, 2024, provided that the vesting of the option may be accelerated, in whole or in part, based on the achievement of certain pre-established company performance criteria, but in no event prior to January 21, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION